Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Correspondence] Reporting of immune checkpoint inhibitor-associated myocarditis

We read with interest the Correspondence by Javid J Moslehi and colleagues,1 who used the WHO Vigibase reporting system, to describe the first case series of severe myocarditis after treatment with immune checkpoint inhibitors—an emerging clinical entity.2 They noted that fatality was increased with combination therapy and saw substantial increases in reporting over time (especially in 2017).

email